Silverfin false false 28/02/2026 28/02/2026 26/02/2025 no description of principal activity Mr G P Beitz 26/02/2025 Dr A Dawson 26/02/2025 Dr Adelle Dawson Greg Patrick Beitz SC839221 2026-02-28 SC839221 bus:Director1 2026-02-28 SC839221 bus:Director2 2026-02-28 SC839221 core:CurrentFinancialInstruments 2026-02-28 SC839221 2025-02-26 2026-02-28 SC839221 bus:Micro-entities 2025-02-26 2026-02-28 SC839221 bus:FilletedAccounts 2025-02-26 2026-02-28 SC839221 bus:AuditExemptWithAccountantsReport 2025-02-26 2026-02-28 SC839221 bus:PrivateLimitedCompanyLtd 2025-02-26 2026-02-28 SC839221 bus:Director1 2025-02-26 2026-02-28 SC839221 bus:Director2 2025-02-26 2026-02-28 SC839221 bus:Director3 2025-02-26 2026-02-28 SC839221 bus:Director4 2025-02-26 2026-02-28 iso4217:GBP xbrli:pure

Company No: SC839221 (Scotland)

# DEESIDE CARDIOLOGY LTD

### UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 26 FEBRUARY 2025 TO 28 FEBRUARY 2026
PAGES FOR FILING WITH THE REGISTRAR

DEESIDE CARDIOLOGY LTD

## UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 26 FEBRUARY 2025 TO 28 FEBRUARY 2026

Contents

DEESIDE CARDIOLOGY LTD

## COMPANY INFORMATION

FOR THE FINANCIAL PERIOD FROM 26 FEBRUARY 2025 TO 28 FEBRUARY 2026
DEESIDE CARDIOLOGY LTD

## COMPANY INFORMATION (continued)

FOR THE FINANCIAL PERIOD FROM 26 FEBRUARY 2025 TO 28 FEBRUARY 2026

DIRECTORS | Mr G P Beitz (Appointed 26 February 2025)
| Dr A Dawson (Appointed 26 February 2025)

REGISTERED OFFICE | C/O Johnston Carmichael Bishop's Court
| 29 Albyn Place
| Aberdeen
| AB10 1YL
| Scotland
| United Kingdom

COMPANY NUMBER | SC839221 (Scotland)

CHARTERED ACCOUNTANTS | Johnston Carmichael LLP
| 15 Academy Street
| Forfar
| DD8 2HA

DEESIDE CARDIOLOGY LTD

## BALANCE SHEET

AS AT 28 FEBRUARY 2026
DEESIDE CARDIOLOGY LTD

## BALANCE SHEET (continued)

FOR THE FINANCIAL PERIOD FROM 26 FEBRUARY 2025 TO 28 FEBRUARY 2026

|  | 28.02.2026
|  | £
Fixed assets |  | 373
Current assets |  | 49,109
Prepayments and accrued income |  | 435
Creditors: amounts falling due within one year |  | ( 12,141)
Net current assets |  | 37,403
Total assets less current liabilities |  | 37,776
Accruals and deferred income |  | ( 2,499)
Net assets |  | 35,277
Capital and reserves |  | 35,277

For the financial period ending 28 February 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Deeside Cardiology Ltd (registered number: SC839221) were approved and authorised for issue by the Board of Directors on 24 May 2026 and were signed on its behalf by:

Dr Adelle Dawson Director |  | Greg Patrick Beitz Director

DEESIDE CARDIOLOGY LTD

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 26 FEBRUARY 2025 TO 28 FEBRUARY 2026
DEESIDE CARDIOLOGY LTD

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the FOR THE FINANCIAL PERIOD FROM 26 FEBRUARY 2025 TO 28 FEBRUARY 2026

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in Scotland (Company no. SC839221). The address of its registered office is C/O Johnston Carmichael Bishop's Court, 29 Albyn Place, Aberdeen, AB10 1YL, Scotland, United Kingdom.

#### 2. Employees

| Period from 26.02.2025 to 28.02.2026
| Number
Monthly average number of persons employed by the Company during the financial period, including directors | 2

#### 3. Directors’ benefits: advances, credit and guarantees

##### Advances

Advances totalling £3,250 were made by the directors in this period and £100 was repaid. No interest is charged in the current year. At 28 February 2026, the company owed £3,150 to the directors.
This loan is unsecured and repayable on demand.